Effects of OMAD and Intermittent Fasting on GLP-1 and Appetite-Regulating Hormones
Intermittent fasting, including OMAD-style patterns, does significantly affect appetite-regulating hormones in the brain, most notably increasing ghrelin levels while showing variable or minimal effects on GLP-1, leptin, and insulin. The evidence demonstrates that fasting patterns alter the hormonal milieu that governs hunger and satiety through central nervous system pathways.
Direct Hormonal Effects of Intermittent Fasting
Ghrelin (The Hunger Hormone)
The most consistent finding across studies is that intermittent fasting significantly increases ghrelin concentrations 1. This orexigenic (appetite-stimulating) hormone rises during fasting periods, which explains the increased hunger sensations experienced during fasting windows. A meta-analysis of Ramadan intermittent fasting (which mimics OMAD patterns with 12-16 hour fasting windows) demonstrated a standardized mean difference of 0.31 pg/mL increase in ghrelin (95% CI: 0.03 to 0.60) 1.
Interestingly, religious fasting appears to produce different hormonal responses than non-religious fasting of equal duration, suggesting that psychological anticipation and circadian alignment may modulate these hormonal changes 2. When participants knew they would fast until sunset (Ramadan), ghrelin levels differed significantly compared to unexpected 12-hour fasts (P = 0.02) 2.
GLP-1 (Glucagon-Like Peptide-1)
The evidence regarding GLP-1 changes with intermittent fasting is more nuanced. GLP-1 levels during religious fasting differ from non-religious fasting (P < 0.001), though the direction and magnitude vary 2.
GLP-1's role in appetite regulation operates primarily through central nervous system pathways. GLP-1 receptors located in the hypothalamus (specifically the arcuate nucleus) and brainstem nuclei (area postrema and nucleus tractus solitarius) mediate appetite, satiety, and energy expenditure 3. When administered centrally in fasted rats, GLP-1 significantly attenuated fasting-induced increases in orexigenic neuropeptides NPY and AgRP, while preventing fasting-induced decreases in anorexigenic neuropeptides POMC and CART 4.
Postprandial GLP-1 responses correlate with brain activation patterns in satiety centers. Higher GLP-1 levels after meals are associated with increased regional cerebral blood flow in the left dorsolateral prefrontal cortex and hypothalamus—areas implicated in satiation and food intake regulation 5. This suggests that the timing and pattern of eating (as in OMAD) may influence how effectively GLP-1 signals satiety to the brain.
Leptin and Insulin
Intermittent fasting shows no significant effect on leptin concentrations (SMD = -0.11 μg/mL, 95% CI: -0.36 to 0.14) across 12 studies 1. Similarly, insulin concentrations remain largely unchanged (SMD = -0.24 μU/mL, 95% CI: -0.54 to 0.02) 1. However, one study found that intermittent fasting does not affect whole-body glucose, lipid, or protein metabolism despite changes in muscle signaling pathways 6.
Brain-Level Mechanisms
Hypothalamic Neuropeptide Regulation
Fasting activates specific neuropeptide pathways in the hypothalamus that GLP-1 can modulate. During fasting, hypothalamic NPY (neuropeptide Y) and AgRP (agouti-related peptide) mRNA expression increases significantly, driving hunger 4. Simultaneously, POMC (proopiomelanocortin) and CART (cocaine- and amphetamine-regulated transcript) expression decreases 4.
GLP-1 administration reverses these fasting-induced changes, suggesting that endogenous GLP-1 fluctuations during intermittent fasting may partially buffer against extreme hunger signals 4. This represents a homeostatic mechanism where the brain attempts to maintain energy balance.
AMPK Pathway
Fasting increases hypothalamic AMP-activated kinase (AMPK) activity, which GLP-1 can suppress. Fasting stimulates AMPKα2 mRNA expression in the hypothalamus, and this increase is almost completely prevented by GLP-1 treatment 4. Since AMPK activation promotes food intake, GLP-1's ability to reverse fasting-induced AMPK activation represents a key mechanism for its anorectic effects 4.
Clinical Implications for OMAD and Intermittent Fasting
Time-Restricted Eating Windows
The timing and duration of eating windows significantly impact metabolic and hormonal responses. Studies show that 8-10 hour eating windows with 14-16 hour fasting periods can enhance fat loss, reduce oxidative stress, and improve cardiovascular endpoints 7. However, spreading eating over >14 hours is associated with poor cardiometabolic health 7.
Most adolescents and adults practicing time-restricted eating self-select late eating windows (11 AM-8 PM), though early time-restricted feeding may offer superior metabolic benefits 7. This suggests that OMAD practitioners should consider meal timing in relation to circadian rhythms for optimal hormonal responses.
Adaptation and Tachyphylaxis
The body adapts to continuous fasting patterns over time. Studies demonstrate that acute or intermittent GLP-1 exposure has more pronounced effects than continuous exposure, suggesting autonomic nervous system adaptation 3. This tachyphylaxis phenomenon means that the hormonal responses to OMAD may diminish with prolonged practice, though metabolic benefits may persist through other mechanisms.
Practical Considerations
Energy Expenditure
Intermittent fasting decreases resting energy expenditure 6. This metabolic adaptation means that without caloric adjustment, weight gain is possible during intermittent fasting despite hormonal changes that might theoretically promote satiety. This represents a critical pitfall for OMAD practitioners who assume the eating pattern alone will produce weight loss.
Individual Variability
High heterogeneity exists in leptin responses across studies 1, indicating substantial individual variation in how people respond hormonally to intermittent fasting. Factors including sex, age, body composition, baseline metabolic health, and psychological factors (stress, sleep, circadian alignment) likely modulate these responses.
Nutrient Adequacy
When practicing OMAD or extended intermittent fasting, ensuring adequate protein intake becomes critical to preserve lean body mass 8. The compressed eating window makes it challenging to consume sufficient nutrients, particularly protein, vitamins, and minerals. This is especially important given that muscle loss can occur with significant caloric restriction.
Comparison with Exogenous GLP-1 Therapy
Exogenous GLP-1 receptor agonists (like semaglutide and tirzepatide) produce far more dramatic effects than endogenous GLP-1 fluctuations from fasting. These medications achieve 14-22% weight loss by continuously activating GLP-1 receptors in the hypothalamus and brainstem 3, 9, 10. The mechanisms include:
- Suppression of appetite through hypothalamic arcuate nucleus activation
- Delayed gastric emptying (though tachyphylaxis develops)
- Increased satiety signaling
- Reduced food intake independent of conscious effort
The hormonal changes from intermittent fasting are modest compared to pharmacologic GLP-1 activation, suggesting that while fasting patterns may optimize endogenous hormone secretion, they cannot replicate the magnitude of effect seen with GLP-1 medications.
Caveats and Limitations
Most evidence comes from Ramadan fasting studies, which may not perfectly translate to secular OMAD practice due to psychological, cultural, and circadian factors 2. The religious context and community support during Ramadan may influence hormonal responses through stress reduction and social reinforcement mechanisms.
Long-term data on OMAD-specific hormonal effects are lacking. Most studies examine 4-12 week interventions, leaving questions about sustained hormonal adaptation over months or years.
The relationship between peripheral hormone levels and central nervous system effects is complex. Circulating hormone concentrations may not directly reflect brain receptor activation or downstream signaling, particularly given blood-brain barrier considerations and local hormone production within the central nervous system 11.